Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy

• Main Authors: Subhash, V.V, Yeo, M.S, Tan, W.L, Yong, W.P
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Review
• Published: 2020
• Subjects: antineoplastic agent; cancer vaccine; chimeric antigen receptor; cytotoxic T lymphocyte antigen 4; dendritic cell vaccine; durvalumab; immunomodulating agent; ipilimumab; mpdl 3280a; nivolumab; pembrolizumab; programmed death 1 ligand 1; T lymphocyte antigen; ticilimumab; tumor antigen; adaptive immunity; adoptive immunotherapy; adoptive transfer; cancer immunization; cancer immunotherapy; cytotoxic T lymphocyte; human; immune evasion; immune response; immune system; immunogenicity; immunosurveillance; innate immunity; multicenter study (topic); natural killer cell; phase 1 clinical trial (topic); phase 2 clinical trial (topic); randomized controlled trial (topic); Review; stomach cancer; T lymphocyte; tumor associated leukocyte; tumor microenvironment; clinical trial (topic); immunity; immunological memory; immunological monitoring; immunology; immunotherapy; procedures; Stomach Neoplasms; Cancer Vaccines; Clinical Trials as Topic; Humans; Immune System Phenomena; Immunologic Memory; Immunotherapy; Monitoring, Immunologic; Tumor Microenvironment
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/176161
• Institution: National University of Singapore

10.1155/2015/308574